← Back to Search

Other

Gabapentin for Autism

Phase < 1
Waitlist Available
Led By David Cochran, MD, PhD
Research Sponsored by University of Massachusetts, Worcester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 hours post-administration
Awards & highlights

Study Summary

This study is evaluating whether a medication may help improve social cognition for individuals with autism spectrum disorder.

Eligible Conditions
  • Autism
  • Autism Spectrum Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 hours post-administration
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 hours post-administration for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cortical GABA in Anterior Cingulate Cortex
Cortical GABA in Right Anterior Insula
Secondary outcome measures
Cortical Glx in Anterior Cingulate Cortex
Cortical Glx in Right Anterior Insula

Side effects data

From 2021 Phase 4 trial • 88 Patients • NCT03012815
2%
Allergic reaction
100%
80%
60%
40%
20%
0%
Study treatment Arm
Gabapentin
Benzodiazepine

Trial Design

1Treatment groups
Experimental Treatment
Group I: GabapentinExperimental Treatment1 Intervention
Single dose of gabapentin 900 mg will be given and neuroimaging markers will be measured before and after administration of gabapentin
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Gabapentin
2013
Completed Phase 4
~1550

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,785 Previous Clinical Trials
2,689,737 Total Patients Enrolled
University of Massachusetts, WorcesterLead Sponsor
343 Previous Clinical Trials
986,591 Total Patients Enrolled
Johns Hopkins UniversityOTHER
2,263 Previous Clinical Trials
14,823,146 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Illinois
Ohio
Washington
How old are they?
< 18
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Study of Neuroimaging Biomarkers of Social Cognition Deficits in Adolescents (Age 13-17) With Autism Spectrum Disorder and Effects of Gabapentin
David Cochran 2017. "Study of Neuroimaging Biomarkers of Social Cognition Deficits in Adolescents (Age 13-17) With Autism Spectrum Disorder and Effects of Gabapentin". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03589898.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top